Therapeutic strategies in traditional Chinese medicine for premature ovarian failure: Modulation of oxidative stress and autophagy–apoptosis via the AMPK/mTOR pathway
BioScience Trends · 2025
DOI: 10.5582/bst.2025.01193 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioScience Trends, 2025. Verfasst von Wenli Cao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Zhoushan Women and Children Hospital, Zhoushan, Zhejiang, China. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Medicine, Chinese Traditional, Drugs, Chinese Herbal, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 102 Literaturangaben.
Abstract (Originalsprache)
Premature ovarian failure (POF), also referred to as premature ovarian insufficiency (POI), is a multifactorial reproductive endocrine disorder characterized by amenorrhea, infertility, hypoestrogenism, and elevated gonadotropin levels before the age of 40. Emerging evidence links its pathogenesis to oxidative stress and dysregulation of the autophagy-apoptosis balance in ovarian cells. Excessive accumulation of reactive oxygen species (ROS) impairs mitochondrial function in oocytes, while aberrant autophagy and granulosa cell apoptosis accelerate the depletion of primordial follicles. The AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) pathway serves as a critical nexus between energy metabolism, oxidative stress, and cell survival. Traditional Chinese medicine (TCM), with its multi-component and multi-target characteristics, has demonstrated unique advantages in modulating the AMPK/mTOR pathway to restore ovarian function. This review synthesizes recent findings on single herbs, classical formulas, and non-pharmacological therapies (acupuncture and moxibustion). Mechanistic studies have revealed that these interventions can activate AMPK, inhibit mTOR overactivation, enhance Nrf2-mediated antioxidant defenses, reduce ROS production, and rebalance autophagy and apoptosis via pathways such as PI3K/Akt and SIRT1/p53. By aligning stage-specific regulation of AMPK/mTOR signaling with the TCM principle of syndrome differentiation, this integrative approach provides theoretical guidance for precise, personalized treatment to optimize multi-target strategies for POF management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhoushan Women and Children Hospital, Zhoushan, Zhejiang, China.
- Zhejiang Ocean University, Zhoushan, Zhejiang, China.
- The First People's Hospital of Wenling (Taizhou University Affiliated Wenling Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang, China.
- Department of Obstetrics and Reproductive Immunology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Obstetrics, The First Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Zitieren
APA
Cao, W., Liu, S., Zhang, L., Fu, X., Li, H., Ye, F., Bei, J., Ren, C., Ni, Y., Zhu, J., & Wang, L. (2025). Therapeutic strategies in traditional Chinese medicine for premature ovarian failure: Modulation of oxidative stress and autophagy–apoptosis via the AMPK/mTOR pathway. BioScience Trends. https://doi.org/10.5582/bst.2025.01193
Vancouver
Cao W, Liu S, Zhang L, Fu X, Li H, Ye F, et al. Therapeutic strategies in traditional Chinese medicine for premature ovarian failure: Modulation of oxidative stress and autophagy–apoptosis via the AMPK/mTOR pathway. BioScience Trends. 2025. doi:10.5582/bst.2025.01193
BibTeX
@article{Cao2025,
author = {Cao, Wenli and Liu, Siling and Zhang, Leifang and Fu, Xiayan and Li, Haiyang and Ye, Feijun and Bei, Jialu and Ren, Chunzhi and Ni, Yanping and Zhu, Jun and Wang, Ling},
title = {Therapeutic strategies in traditional Chinese medicine for premature ovarian failure: Modulation of oxidative stress and autophagy–apoptosis via the AMPK/mTOR pathway},
journal = {BioScience Trends},
year = {2025},
doi = {10.5582/bst.2025.01193}
}
EUVIMED